Related Experiment Videos
Beta-2-microglobulin-specific autoantibodies cause platelet aggregation and interfere with ADP-induced aggregation
Clinical and Experimental Immunology
|January 1, 1982
Summary
Autoimmune diseases can involve beta-2-microglobulin (beta 2m) autoantibodies affecting platelet function. These autoantibodies can cause platelet aggregation and impair responses to ADP, suggesting a role in disease pathogenesis.
Area of Science:
- Immunology
- Hematology
- Rheumatology
Background:
- Beta-2-microglobulin (beta 2m) is a protein found on cell surfaces.
- Autoantibodies against beta 2m are observed in various autoimmune diseases.
- The role of these autoantibodies in platelet function is not fully understood.
Purpose of the Study:
- To investigate the anti-platelet activity of beta-2-microglobulin (beta 2m) specific autoantibodies.
- To determine if these autoantibodies influence platelet aggregation.
- To explore the presence of these autoantibodies on platelets and lymphocytes in patients with autoimmune conditions.
Main Methods:
- Direct platelet aggregation assays.
- Adenosine diphosphate (ADP)-induced platelet aggregation assays.
- Desorption of antibodies from patient cells (platelets and lymphocytes).
Main Results:
- Human anti-beta 2m autoantibodies and heterologous rabbit anti-beta 2m antibodies induced dose-dependent aggregation of human platelets.
- Anti-beta 2m autoantibodies impaired ADP-induced platelet aggregation.
- Beta 2m specific autoantibodies were found on platelets and lymphocytes of a patient with systemic lupus erythematosus.
Conclusions:
- Beta-2-microglobulin (beta 2m) specific autoantibodies possess anti-platelet activity.
- These autoantibodies can induce platelet aggregation and inhibit ADP-induced aggregation.
- The presence of these autoantibodies on blood cells suggests a potential mechanism by which they may alter platelet function in autoimmune diseases.